Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer. [electronic resource]
- Journal of the National Cancer Institute Jan 1995
- 58-60 p. digital
Publication Type: Letter
0027-8874
10.1093/jnci/87.1.58 doi
Antineoplastic Combined Chemotherapy Protocols--adverse effects Etoposide--administration & dosage Humans Leukemia--chemically induced Male Neoplasms, Second Primary--chemically induced Testicular Neoplasms--drug therapy